Antitumor Activity of Dehydroxymethylepoxyquinomicin (DHMEQ) in Monotherapy and Combination with Cisplatin in the SKOV-3 Ovarian Cancer Model. J. Can. Res. Updates. 2024;13:12-18. doi:10.30683/1929-2279.2024.13.03